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1999 and by September 2000 had fallen no further.
Whether it will hold up under the latest media
onslaught remains to be seen. Incorrect media reports
of vaccine uptake “plummeting” could become a
self›fulfilling prophecy.
Wakefield and Montgomery’s review provides no
justification for offering the single antigens.1 But this is
not the media’s interpretation. However weak the scien›
tific evidence which triggers vaccine safety scares, they
provoke anxiety among parents and health profession›
als which can lead to a decline in vaccine uptake. The
pertussis vaccine scare in the 1970s was based on
similarly flawed research and resulted in unnecessary
suffering and deaths.16 We need urgently to identify and
use the most effective methods for training and updating
health professionals so that they can respond promptly
and appropriately to parents’ concerns.
This is not the first time a potentially damaging
piece of research related to vaccine safety from the
same authors has been discussed in the popular press
before most clinicians have a chance to read it in a peer
reviewed journal. This practice compounds the
difficulties for health professionals in accessing the
information needed to answer parents’ queries. More›
over, researchers whose findings are likely to cause
concern to many, in this case millions, of people have
an obligation to ensure that their study is of the high›
est standard. Unusually the editor of the journal that
published the review has also published the referees’
comments. These reveal that specialists in immunisa›
tion were not included—that too seems to have been an
important error of omission.
David Elliman consultant in community child health
St George’s Hospital, London SW17 0QT
(DavidElliman@compuserve.com)
Helen Bedford senior research fellow
Institute of Child Health, London WC1N 1EH
(h.bedford@ich.ucl.ac.uk)
Both authors have received funding from vaccine manufactur›
ers as well as other sources to attend educational meetings and
conduct research.
1 Wakefield AJ, Montgomery SM. Mumps measles rubella vaccine:
Through a glass darkly. Adverse Drug React Toxicol Rev 2000;19:265›83.
2 Peltola H, Heinonen OP. Frequency of true adverse reactions to measles›
mumps›rubella vaccine. A double›blind placebo›controlled trial in twins.
Lancet 1986;1:939›42.
3 Stokes Jr J, Weibel RE, Villarejos VM, Arguedas JA, Buynak EB, Hilleman
MR. Trivalent combined measles›mumps›rubella vaccine. JAMA 1971;
218:57›61.
4 Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan Capner P,
et al. A new method for active surveillance of adverse events from
diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
Lancet 1995;345:567›9.
5 Gillberg C, Heijbel H. MMR and autism. Autism 1998;2:423›4.
6 Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence
for measles, mumps and rubella vaccine associated inflammatory bowel
disease or autism in a 14›year prospective study. Lancet 1998;351:1327›8.
7 Taylor BME, Farrington CP, Petropoulos M›C, Favot›Mayaud I, Li J, Waight
PA. Autism and measles, mumps and rubella vaccine: no epidemiological
evidence for a causal association. Lancet 1999;353:2026›9.
8 Jatja A, Davidkin I, Kurki T, Kallio MJT, Valle M, Peltola H. Serious adverse
events after measles›mumps›rubella vaccination during a fourteen›year
prospective follow›up. Pediatr Infect Dis J 2000;19:1127›34.
9 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al.
Ileal›lymphoid nodular hyperplasia, non›specific colitis, and pervasive
developmental disorder in children. Lancet 1998;351:1327›8.
10 Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and
rubella vaccine: questionnaire survey of health professionals. BMJ
2001;322: 82›5.
11 Department of Health. Immunisation against infectious disease. London:
HMSO, 1996.
12 Harris T, Gibbons CR, Churchill M, Copping J. Primary care profession›
als’ knowledge of contraindications. Community Practitioner 2001;74:66›7.
13 Peckham C, Bedford H, Senturia Y, Ades. A. National immunisation study:
factors influencing immunisation uptake in childhood. Horsham: Action
Research, 1989.
14 Pareek M, Pattison HM. The two›dose measles, mumps and rubella
(MMR) immunisation schedule: factors affecting maternal intention to
vaccinate. Br J Gen Pract 2000;50:969›71.
15 Department of Health. MMR Factsheet (2). London: Health Education
Authority, 1998.
16 Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE,
Miller E, et al. Impact of anti›vaccine movements on pertussis control.
Lancet 1998;351:356›61.
How policy informs the evidence
“Evidence based” thinking can lead to debased policy making
Who would not want health policy to bebased on evidence? “Evidence based medi›cine” and “evidence based policy” have such
reassuring and self evidently desirable qualities that it
may seem contrary to question their legitimacy in rela›
tion to reducing health inequalities. However, these
terms are now so familiar that it is easy to forget the
important question about what sort of data provide
appropriate evidence for particular types of decisions.
The sort of evidence gathered on the benefits of inter›
ventions aimed at individuals may not help in guiding
policies directed towards reducing health inequalities.
In this week’s BMJ readers have the opportunity to
assess part of the process leading to the recommenda›
tions of the Independent Inquiry into Health Inequali›
ties (the Acheson inquiry),1 established in 1997 to help
the government formulate policy to reduce health
inequalities. The inquiry established an evaluation group
to report on the quality of the evidence it used to reach
its conclusions and support its recommendations.2 This
group critiqued submissions to the inquiry, and a list of
its own remedies for health inequalities—their “10 steps
to health equality”—was released before the Acheson
inquiry had itself reported (see box on bmj.com).3
The evaluation group appears to have applied evi›
dence based principles to its consideration of ways to
reduce inequalities in health. Essentially it wanted evi›
dence from controlled intervention studies, and its
main evaluation consisted of checking each rec›
ommendation against three earlier reviews (two
conducted within an explicit evidence based frame›
work) and the Cochrane Library.
The task of the Acheson inquiry was to make
recommendations that would reduce inequalities in
health, not merely have a positive overall health
benefit. For most of the evaluation group’s suggested
interventions there are no high quality controlled
studies showing that they would reduce health
inequalities—for example, the evidence that fluorida›
tion of drinking water would reduce inequalities in
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dental health is scanty.4 Indeed, some of these
interventions could increase inequalities. Smoking ces›
sation may be more successful in advantaged groups.
Drugs education in schools may have less impact on
those most at risk, because they are more likely to be
truants and thus less exposed to it.
On the general question of what sort of evidence is
useful to set policy in the public health domain, it is
helpful to think back to earlier eras. In the first half of
the 19th century there were no “evaluation groups” to
point out the lack of evidence from controlled
intervention studies showing the health benefits of, for
example, stopping children under 9 from working in
cotton mills, fencing off dangerous machinery, or
reducing the number of hours children could work to
only 10 a day. With an evaluation group, implementa›
tion of the Factory Acts could have been resisted. The
factory owners were certainly keen on “evidence”: the
claim that working class children aged 5›10 had lower
death rates than middle class children was used to sug›
gest that factory labour was good for the under 10s.5
Clearly the situation is now different, but health
inequalities are still large and have increased over the
past two decades.6 Premature death rates are over three
and a half times higher in Glasgow Shettleston than in
Wokingham,6 and a remarkable three quarters of
premature deaths in Glasgow Shettleston would not
occur if it had the mortality rates of Wokingham. It is
no surprise that in Glasgow Shettleston child poverty
rates are over six times, and unemployment rates over
five times, higher than in Wokingham. Clearly the need
is for substantial reductions in socioeconomic inequal›
ity, which can follow only from the concerted
implementation of policies of progressive taxation and
substantial income redistribution.
The evaluation group states that randomised trials
of income support have been carried out and could, in
principle, have examined health outcomes.7 However,
the effects of income redistribution would not be to
give a few people a little more money while they
remain living in a highly unequal society, but to change
the nature of the society. Health is influenced by micro
and macro social environments,8 and societies with
high levels of income inequality are characterised by a
wide range of social›structural attributes that have a
detrimental impact on health.9
As Schwartz and Carpenter have pointed out, inap›
propriately focusing on individual level determinants
of health while ignoring more important macrolevel
determinants is tantamount to obtaining the right
answer to the wrong question.10 Consider the situation
of examining risk factors for unemployment. Conven›
tional individual›level studies would probably find that
low education, not dressing smartly for interviews,
being short, being over 50, or being a member of a
minority ethnic group predict being unemployed.
Indeed these “risk factors” would probably explain a
high percentage of the variance in unemployment. A
controlled study finding that counselling on how to
dress and behave at job interviews increases success in
getting a job could be added to the Cochrane Library.
The same risk factors may explain a high percentage of
the intra›individual variance in unemployment, both
when unemployment is 1% and when it is 14%.
The big difference for the population—and thus for
the individual risk of unemployment—is, however, the
14›fold difference in overall levels of unemployment at
times when different fiscal policies are being imple›
mented. High variance apparently “explained” by
individual›level risk indicators (or markers manipula›
ble in a discrete way within populations) does not
mean that they are important determinants of the
population level of any outcome.11 These are, however,
precisely the factors that evidence based research
focuses on. Despite occasional rhetorical interest in
wider determinants of health, evidence based assess›
ments are largely restricted to individualised interven›
tions. The Cochrane Library is unlikely ever to contain
systematic reviews or trials of the effects of redistribu›
tive national fiscal policies, or of economic investment
leading to reductions in unemployment, on health.
The insidious nature of this mismatch between evi›
dence and policy is highlighted by the fact that the
evaluation group is, as one would expect of such
informed commentators, aware of the problem, while
implicitly ignoring it. One of the evaluation group
stated when launching the “10 steps to health equity”,
“Our recommendations are quite medical because
those are the sort that tend to have evidence behind
them.”3 Health differentials between social groups, or
between poor and rich countries, are not primarily
generated by medical causes and require solutions at a
different level.
One source of the scientific innovation that was
institutionalised within the Cochrane Collaboration
was a powerful critique of a complacent and uncritical
form of health care delivery.12 The establishment of the
evidence based medicine movement is a remarkable
achievement with an unquestionably favourable
influence on the probability that individuals will receive
health care that benefits them and be protected from
interventions that harm them. It would be ironic, and
inconsistent with Cochrane’s radical instincts, if the
inappropriate applications of those ideas were to pro›
vide a complacent barrier to implementing those
measures necessary to redress health inequalities.
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